Therapeutic Riding and Neuromuscular Disease

Phase 1

Completed

• Conditions: Neuromuscular Disease
• Interventions: Other: Therapeutic Riding/ Hippotherapy Intervention

• Registration Number: NCT01621984
• Lead Sponsor: University of Ioannina

Brief Summary

The purpose of this current prospective study is to assess the effects of a Therapeutic Riding exercise program conducted in patients suffering from neuromuscular disease. The exercise intervention aims at improving gross motor function, gross motor performance, balance, spasticity, posture and quality of life. Patients were randomized according to age, sex, mental ability and gross motor function. Furthermore, patients will be subdivided into categories of central nervous system (brain/ spinal cord) and peripheral (peripheral nerve or muscle) diseases. The exercise program duration will be 12 weeks, once a week with 30-40 minutes sessions. Six measurements will be conducted: the Gross Motor Function Measure, the Gross Motor Performance Measure, the Quality of life Questionnaire for Children, the Pediatric Balance Scale, the dynamic plate in combination with x-ray for posture control, the Modified Ashworth Scale for spasticity and the Wisc 3 for mental ability. The results will be collected and evaluated using the statistical programme SPSS.

Detailed Description

Not available

Study Timeline

• Study Start: 2012-06
• Study First Submitted: 2012-06-12
• Study First Submitted QC: 2012-06-15
• Study First Posted: 2012-06-18
• Primary Completion: 2016-10
• Study Completion: 2016-10
• Status Verified: 2018-11
• Last Update Submitted: 2018-11-15
• Last Update Posted: 2018-11-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

• Children with neuromuscular disease
• Parental consent
• Sitting posture capability
• Hip abduction capability on horseback
• Ability to communicate and collaborate with the researcher

Exclusion Criteria

• Children with Scheuermann disease
• uncontrolled seizures (A) child with generalized seizure over 2 minutes in the last three months (B) Children who are not well-adjusted levels of antiepileptic drugs.
• musculoskeletal disorder that may be aggravated by the movement of the horse such as atlantoaxial instability, osteoporosis etc.
• Scoliosis > 30 degree
• Allergy to dust

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Therapeutic Riding/ Hippotherapy	Therapeutic Riding/ Hippotherapy Intervention	12 week Therapeutic Riding program that focused on gross motor function, gross motor performance, balance, spasticity, posture and quality of life

Primary Outcome Measures

Name	Time	Method
Change from baseline in posture control at different time points	Measures will be done: 1 two months before treatment, 2 one month before treatment, 3 one day before start of treatment, 4 six weeks after the start of treatment, 5 twelve weeks, the end of treatment 6 two months after the end of treatment.	posture control measured by the dynamic plate in combination with x-ray.
Change from baseline in balance at different time points	Measures will be done: 1 two months before treatment, 2 one month before treatment, 3 one day before start of treatment, 4 six weeks after the start of treatment, 5 twelve weeks, the end of treatment 6 two months after the end of treatment.	Balance measured by the Pediatric Balance Scale

Secondary Outcome Measures

Name	Time	Method
Improvement in Gross Motor Function	Measures will be done: 1 two months before treatment, 2 one month before treatment, 3 just before treatment, 4 six weeks after the start of treatment, 5 twelve weeks, the end of treatment 6 two months after the end of treatment.	Gross Motor Function measured by the Gross Motor Function Measure (GMFM)
Improvement in Quality of life	Measures will be done: 1 two months before treatment, 2 one month before treatment, 3 just before treatment, 4 six weeks after the start of treatment, 5 twelve weeks, the end of treatment 6 two months after the end of treatment.	Quality of life measured by the Quality of life Questionnaire for Children
Improvement in Gross Motor Performance	Measures will be done: 1 two months before treatment, 2 one month before treatment, 3 just before treatment, 4 six weeks after the start of treatment, 5 twelve weeks, the end of treatment 6 two months after the end of treatment.	Gross Motor Performance measured by the Gross Motor Performance Measure (GMPM)
Decrease of spasticity	Measures will be done: 1 two months before treatment, 2 one month before treatment, 3 just before treatment, 4 six weeks after the start of treatment, 5 twelve weeks, the end of treatment 6 two months after the end of treatment.	Spastisity measured by the Modified Ashworth Scale

Trial Locations

Locations (1)

University Hospital of Ioannina; 🇬🇷 Ioannina, Greece